These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30666806)

  • 1. Identifying the binding mechanism of LEAP2 to receptor GHSR1a.
    Wang JH; Li HZ; Shao XX; Nie WH; Liu YL; Xu ZG; Guo ZY
    FEBS J; 2019 Apr; 286(7):1332-1345. PubMed ID: 30666806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying key residues and key interactions for the binding of LEAP2 to receptor GHSR1a.
    Li HZ; Shou LL; Shao XX; Liu YL; Xu ZG; Guo ZY
    Biochem J; 2020 Sep; 477(17):3199-3217. PubMed ID: 32803260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LEAP2 has antagonized the ghrelin receptor GHSR1a since its emergence in ancient fish.
    Li HZ; Shou LL; Shao XX; Li N; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2021 Jun; 53(6):939-949. PubMed ID: 33966114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin.
    Holá L; Železná B; Karnošová A; Kuneš J; Fehrentz JA; Denoyelle S; Cantel S; Blechová M; Sýkora D; Myšková A; Maletínská L
    J Pharmacol Exp Ther; 2022 Nov; 383(2):129-136. PubMed ID: 36198495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.
    M'Kadmi C; Cabral A; Barrile F; Giribaldi J; Cantel S; Damian M; Mary S; Denoyelle S; Dutertre S; Péraldi-Roux S; Neasta J; Oiry C; Banères JL; Marie J; Perello M; Fehrentz JA
    J Med Chem; 2019 Jan; 62(2):965-973. PubMed ID: 30543423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin and LEAP-2: Rivals in Energy Metabolism.
    Al-Massadi O; Müller T; Tschöp M; Diéguez C; Nogueiras R
    Trends Pharmacol Sci; 2018 Aug; 39(8):685-694. PubMed ID: 30037389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-Expressed Antimicrobial Peptide 2 antagonizes the insulinostatic effect of ghrelin in rat isolated pancreatic islets.
    Bayle M; Péraldi-Roux S; Gautheron G; Cros G; Oiry C; Neasta J
    Fundam Clin Pharmacol; 2022 Apr; 36(2):375-377. PubMed ID: 34449915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor.
    Ge X; Yang H; Bednarek MA; Galon-Tilleman H; Chen P; Chen M; Lichtman JS; Wang Y; Dalmas O; Yin Y; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD
    Cell Metab; 2018 Feb; 27(2):461-469.e6. PubMed ID: 29233536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region.
    Barrile F; M'Kadmi C; De Francesco PN; Cabral A; García Romero G; Mustafá ER; Cantel S; Damian M; Mary S; Denoyelle S; Banères JL; Marie J; Raingo J; Fehrentz JA; Perelló M
    Mol Cell Endocrinol; 2019 Dec; 498():110573. PubMed ID: 31499133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GHSR signalling in perinatal phases is involved in liver metabolism at puberty.
    Ferreira-Junior MD; Cavalcante KVN; Xavier CH; Vanzela EC; Boschero AC; Matafome P; Gomes RM
    J Endocrinol; 2024 Oct; 263(1):. PubMed ID: 39045853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humans.
    Englund A; Gilliam-Vigh H; Suppli MP; Gasbjerg LS; Vilsbøll T; Knop FK
    Peptides; 2024 Jul; 177():171227. PubMed ID: 38657907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-induced LEAP2 and GHSR1a knockout mutant zebrafish displayed abnormal growth and impaired lipid metabolism.
    Fei Y; Bao Z; Wang Q; Zhu Y; Lu J; Ouyang L; Hu Q; Zhou Y; Chen L
    Gen Comp Endocrinol; 2024 Sep; 355():114563. PubMed ID: 38830459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis.
    Francisco V; Tovar S; Conde J; Pino J; Mera A; Lago F; González-Gay MA; Dieguez C; Gualillo O
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32268520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2.
    Holm S; Husted AS; Skov LJ; Morville TH; Hagemann CA; Jorsal T; Dall M; Jakobsen A; Klein AB; Treebak JT; Knop FK; Schwartz TW; Clemmensen C; Holst B
    Endocrinology; 2022 Jun; 163(6):. PubMed ID: 35352108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model.
    Cornejo MP; Castrogiovanni D; Schiöth HB; Reynaldo M; Marie J; Fehrentz JA; Perello M
    J Neuroendocrinol; 2019 Oct; 31(10):e12785. PubMed ID: 31469195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual orthologs shed new light on the binding mechanism of ghrelin to its receptor GHSR1a.
    Li HZ; Shao XX; Shou LL; Li N; Liu YL; Xu ZG; Guo ZY
    Arch Biochem Biophys; 2021 Jun; 704():108872. PubMed ID: 33857472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin receptor activity amplifies hippocampal N-methyl-d-aspartate receptor-mediated postsynaptic currents and increases phosphorylation of the GluN1 subunit at Ser896 and Ser897.
    Muniz BG; Isokawa M
    Eur J Neurosci; 2015 Dec; 42(12):3045-53. PubMed ID: 26490687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of POMC neurons in LEAP2 regulation of food intake and body weight.
    Chu G; Peng H; Yu N; Zhang Y; Lin X; Lu Y
    Front Endocrinol (Lausanne); 2022; 13():932761. PubMed ID: 36387867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEAP2 is a more conserved ligand than ghrelin for fish GHSRs.
    Li HZ; Shao XX; Wang YF; Liu YL; Xu ZG; Guo ZY
    Biochimie; 2023 Jun; 209():10-19. PubMed ID: 36669723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays.
    Sturaro C; Ruzza C; Ferrari F; Pola P; Argentieri M; Frezza A; Marzola E; Bettegazzi B; Cattaneo S; Pietra C; Malfacini D; Calò G
    Eur J Pharmacol; 2024 Oct; 981():176880. PubMed ID: 39128804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.